Giuseppe Palmieri
Giuseppe Palmieri
Professore di Oncologia Medica
Verified email at
Cited by
Cited by
Mutations of the BRAF gene in human cancer
H Davies, GR Bignell, C Cox, P Stephens, S Edkins, S Clegg, J Teague, ...
Nature 417 (6892), 949-954, 2002
The role of BRAF V600 mutation in melanoma
PA Ascierto, JM Kirkwood, JJ Grob, E Simeone, AM Grimaldi, M Maio, ...
Journal of translational medicine 10, 1-9, 2012
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma
M Colombino, M Capone, A Lissia, A Cossu, C Rubino, V De Giorgi, ...
Journal of Clinical Oncology 30, 2522-2529, 2012
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
AM Grimaldi, E Simeone, D Giannarelli, P Muto, S Falivene, V Borzillo, ...
Oncoimmunology 3 (5), e28780, 2014
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab
M Capone, D Giannarelli, D Mallardo, G Madonna, L Festino, AM Grimaldi, ...
Journal for immunotherapy of cancer 6, 1-7, 2018
Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer
C Jones, A Mackay, A Grigoriadis, A Cossu, JS Reis-Filho, L Fulford, ...
Cancer research 64 (9), 3037-3045, 2004
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma
E Simeone, G Gentilcore, D Giannarelli, AM Grimaldi, C Caracò, ...
Cancer immunology, immunotherapy 63, 675-683, 2014
Main roads to melanoma
G Palmieri, M Capone, ML Ascierto, G Gentilcore, DF Stroncek, M Casula, ...
Journal of translational medicine 7, 1-17, 2009
HCV-related hepatocellular carcinoma: From chronic inflammation to cancer
G Castello, S Scala, G Palmieri, SA Curley, F Izzo
Clinical immunology 134 (3), 237-250, 2010
Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells
M Pisano, G Pagnan, M Loi, ME Mura, MG Tilocca, G Palmieri, D Fabbri, ...
Molecular cancer 6, 1-12, 2007
NF-κB as potential target in the treatment of melanoma
G Madonna, CD Ullman, G Gentilcore, G Palmieri, PA Ascierto
Journal of translational medicine 10, 1-8, 2012
Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis
A D'Angelo, L Garzia, A André, P Carotenuto, V Aglio, O Guardiola, ...
Cancer cell 5 (2), 137-149, 2004
X-inactivation patch size in human female tissue confounds the assessment of tumor clonality
M Novelli, A Cossu, D Oukrif, A Quaglia, S Lakhani, R Poulsom, P Sasieni, ...
Proceedings of the National Academy of Sciences 100 (6), 3311-3314, 2003
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis
P Liu, M Ge, J Hu, X Li, L Che, K Sun, L Cheng, Y Huang, MG Pilo, ...
Hepatology 66 (1), 167-181, 2017
Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression
G Palmieri, M Strazzullo, PA Ascierto, SMR Satriano, A Daponte, ...
Journal of clinical oncology 17 (1), 304-304, 1999
MC1R variants increased the risk of sporadic cutaneous melanoma in darker‐pigmented Caucasians: A pooled‐analysis from the M‐SKIP project
E Pasquali, JC García‐Borrón, MC Fargnoli, S Gandini, P Maisonneuve, ...
International journal of cancer 136 (3), 618-631, 2015
Molecular epidemiology of the main druggable genetic alterations in non-small cell lung cancer
SS Fois, P Paliogiannis, A Zinellu, AG Fois, A Cossu, G Palmieri
International journal of molecular sciences 22 (2), 612, 2021
Multiple molecular pathways in melanomagenesis: characterization of therapeutic targets
G Palmieri, MN Ombra, M Colombino, M Casula, MC Sini, A Manca, ...
Frontiers in oncology 5, 183, 2015
Sensitivity and specificity of epiluminescence microscopy: evaluation on a sample of 2731 excised cutaneous pigmented lesions
PA Ascierto, G Palmieri, E Celentano, R Parasole, C Caracò, A Daponte, ...
British Journal of Dermatology 142 (5), 893-898, 2000
Sequencing of ipilimumab plus nivolumab and encorafenib plus binimetinib for untreated BRAF-mutated metastatic melanoma (SECOMBIT): a randomized, three-arm, open-label phase II …
PA Ascierto, M Mandalà, PF Ferrucci, M Guidoboni, P Rutkowski, ...
Journal of Clinical Oncology 41 (2), 212-221, 2023
The system can't perform the operation now. Try again later.
Articles 1–20